• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化和非小细胞肺癌的共同生物标志物和机制。

Shared biomarkers and mechanisms in idiopathic pulmonary fibrosis and non-small cell lung cancer.

机构信息

Department of Pulmonary and Critical Care Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, Jiangsu, China.

Department of Thoracic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, Jiangsu, China.

出版信息

Int Immunopharmacol. 2024 Jun 15;134:112162. doi: 10.1016/j.intimp.2024.112162. Epub 2024 May 3.

DOI:10.1016/j.intimp.2024.112162
PMID:38703565
Abstract

BACKGROUND

Epidemiological evidence has indicated the occurrence of idiopathic pulmonary fibrosis (IPF) with coexisting lung cancer is not a coincidence. The pathogenic mechanisms shared between IPF and non-small cell lung cancer (NSCLC) at the transcriptional level remain elusive and need to be further elucidated.

METHODS

IPF and NSCLC datasets of expression profiles were obtained from the GEO database. Firstly, to detect the shared dysregulated genes positively correlated with both IPF and NSCLC, differentially expressed analysis and WGCNA analysis were carried out. Functional enrichment and the construction of protein-protein network were employed to reveal pathogenic mechanisms related to two diseases mediated by the shared dysregulated genes. Then, the LASSO regression was adopted for screening critical candidate biomarkers for two disorders. Moreover, ROC curves were applied to evaluate the diagnostic value of the candidate biomarkers in both IPF and NSCLC.

RESULTS

The 20 shared dysregulated genes positively correlated with both IPF and NSCLC were identified after intersecting differentially expressed analysis and WGCNA analysis. Functional enrichment revealed the 20 shared genes mostly enriched in extracellular region, which is critical in the organization of extracellular matrix. The protein-protein networks unrevealed the interaction of the 11 shared genes involving in collagen deposition and the connection between PYCR1 with PSAT1. PSAT1, PYCR1, COL10A1 and KIAA1683 were screened by the LASSO regression. ROC curves comprising area under the curve (AUC) verified the potential diagnostic value of PSAT1 and COL10A1 in both IPF and NSCLC.

CONCLUSIONS

We revealed dysregulated extracellular matrix through aberrant expression of the relevant genes, which provided further understanding for the common molecular mechanisms predisposing the occurrence of both IPF and NSCLC.

摘要

背景

流行病学证据表明,特发性肺纤维化(IPF)合并肺癌的发生并非偶然。IPF 和非小细胞肺癌(NSCLC)在转录水平上的共同发病机制仍不清楚,需要进一步阐明。

方法

从 GEO 数据库中获取 IPF 和 NSCLC 数据集的表达谱。首先,为了检测与 IPF 和 NSCLC 均呈正相关的共享失调基因,进行差异表达分析和 WGCNA 分析。采用功能富集和蛋白质-蛋白质网络构建,揭示由共享失调基因介导的与两种疾病相关的发病机制。然后,采用 LASSO 回归筛选两种疾病的关键候选生物标志物。此外,应用 ROC 曲线评估候选生物标志物在 IPF 和 NSCLC 中的诊断价值。

结果

通过差异表达分析和 WGCNA 分析的交集,鉴定出与 IPF 和 NSCLC 均呈正相关的 20 个共享失调基因。功能富集揭示了 20 个共享基因主要富集在外分泌区域,这对外泌基质的组织至关重要。蛋白质-蛋白质网络揭示了 11 个共享基因涉及胶原蛋白沉积的相互作用,以及 PYCR1 与 PSAT1 之间的联系。通过 LASSO 回归筛选出 PSAT1、PYCR1、COL10A1 和 KIAA1683。ROC 曲线(包括曲线下面积(AUC))验证了 PSAT1 和 COL10A1 在 IPF 和 NSCLC 中的潜在诊断价值。

结论

我们通过相关基因的异常表达揭示了失调的细胞外基质,为理解导致 IPF 和 NSCLC 共同发生的共同分子机制提供了进一步的认识。

相似文献

1
Shared biomarkers and mechanisms in idiopathic pulmonary fibrosis and non-small cell lung cancer.特发性肺纤维化和非小细胞肺癌的共同生物标志物和机制。
Int Immunopharmacol. 2024 Jun 15;134:112162. doi: 10.1016/j.intimp.2024.112162. Epub 2024 May 3.
2
High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis.肺纤维化和非小细胞肺癌中高补体蛋白 C1q 水平与预后不良相关。
BMC Cancer. 2022 Jan 25;22(1):110. doi: 10.1186/s12885-021-08912-3.
3
Identification of common signatures in idiopathic pulmonary fibrosis and lung cancer using gene expression modeling.使用基因表达建模鉴定特发性肺纤维化和肺癌的共同特征。
BMC Cancer. 2020 Oct 12;20(1):986. doi: 10.1186/s12885-020-07494-w.
4
Construction of an artificial neural network diagnostic model and investigation of immune cell infiltration characteristics for idiopathic pulmonary fibrosis.构建人工神经网络诊断模型并探讨特发性肺纤维化的免疫细胞浸润特征。
BMC Pulm Med. 2024 Sep 17;24(1):458. doi: 10.1186/s12890-024-03249-6.
5
Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.基于生物信息学分析的非小细胞肺癌诊断和预后关键生物标志物的鉴定和整合分析。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211060202. doi: 10.1177/15330338211060202.
6
[Identification of SULF1 as a Shared Gene in Idiopathic Pulmonary Fibrosis
and Lung Adenocarcinoma].[鉴定SULF1作为特发性肺纤维化和肺腺癌中的共享基因]
Zhongguo Fei Ai Za Zhi. 2023 Sep 20;26(9):669-683. doi: 10.3779/j.issn.1009-3419.2023.101.25.
7
The molecular mechanism underlying dermatomyositis related interstitial lung disease: evidence from bioinformatic analysis and validation.皮肌炎相关间质性肺病的分子机制:生物信息学分析和验证的证据。
Front Immunol. 2023 Oct 19;14:1288098. doi: 10.3389/fimmu.2023.1288098. eCollection 2023.
8
Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis.综合生物信息学分析鉴定和验证特发性肺纤维化的潜在生物标志物和途径。
Biomed Res Int. 2021 Jul 4;2021:5545312. doi: 10.1155/2021/5545312. eCollection 2021.
9
Combining single-cell RNA sequencing data and transcriptomic data to unravel potential mechanisms and signature genes of the progression of idiopathic pulmonary fibrosis to lung adenocarcinoma and predict therapeutic agents.结合单细胞 RNA 测序数据和转录组数据,揭示特发性肺纤维化向肺腺癌进展的潜在机制和特征基因,并预测治疗药物。
Funct Integr Genomics. 2023 Nov 24;23(4):346. doi: 10.1007/s10142-023-01274-y.
10
Weighted Gene Coexpression Network Analysis Identifies Key Genes and Pathways Associated with Idiopathic Pulmonary Fibrosis.加权基因共表达网络分析鉴定与特发性肺纤维化相关的关键基因和通路。
Med Sci Monit. 2019 Jun 9;25:4285-4304. doi: 10.12659/MSM.916828.

引用本文的文献

1
The key enzyme PYCR1 in proline metabolism: a dual driver of cancer progression and fibrotic remodeling.脯氨酸代谢中的关键酶PYCR1:癌症进展和纤维化重塑的双重驱动因素
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2545620. doi: 10.1080/14756366.2025.2545620. Epub 2025 Sep 2.